Search results
Showing 1996 to 2010 of 9008 results
Osteoporosis: risk assessment, treatment, and fragility fracture prevention (update)
In development Reference number: GID-NG10216 Expected publication date: 29 July 2026
In development Reference number: GID-TA10046 Expected publication date: 22 November 2017
Rozanolixizumab for treating antibody-positive generalised myasthenia gravis [ID5092]
In development Reference number: GID-TA10994 Expected publication date: TBC
Inebilizumab for treating generalised myasthenia gravis [ID6587] [TSID12110]
Awaiting development Reference number: GID-TA11667 Expected publication date: TBC
Upadacitinib for treating moderately to severely active systemic lupus erythematosus [TSID12366]
Awaiting development Reference number: GID-TA12021 Expected publication date: TBC
Obinutuzumab for treating primary membranous nephropathy [ID6751]
Awaiting development Reference number: GID-TA11983 Expected publication date: TBC
Awaiting development Reference number: GID-TA11876 Expected publication date: TBC
Awaiting development Reference number: GID-TA11919 Expected publication date: TBC
Topic prioritisation
Fetoscopic tracheal occlusion (FETO) for severe congenital diaphragmatic hernia
Topic prioritisation
Topic prioritisation
Aflibercept for untreated retinopathy in babies born preterm TS ID 11943
Topic prioritisation